Source: PaxForex Premium Analytics Portal, Fundamental Insight German Retail Sales for May increased by 13.9% monthly and by 3.8% annualized. Economists predicted an increase of 3.9% monthly and a decrease of 3.5% annualized. Forex traders can compare this to German Retail Sales for April, which decreased by 6.5% monthly and by 6.4% annualized. The German Unemployment Change for June was reported at 69K and the German Unemployment Rate at 6.4%. Economists predicted a reading of 120K and of 6.6%. Forex traders can compare this to the...
Source: PaxForex Premium Analytics Portal, Fundamental Insight Alibaba (NYSE: BABA) shares have grown by more than 140% since its debut in the U.S. in late 2014. It was already a technical titan in China, playing a crucial role in the lives of many Chinese consumers and businesses. This is evidenced by the fact that Alibaba soon after its U.S. IPO reported revenues for the fiscal year 2015 in the amount of 12.3 billion U.S. dollars. However, the company has just completed the fiscal year 2020 (the year ended March 31, 2020) and reported...
Source: PaxForex Premium Analytics Portal, Fundamental Insight The final UK GDP for the first quarter decreased by 2.2% quarterly and by 1.7% annualized. Economists predicted a decrease of 2.0% quarterly and 1.6% annualized. Forex traders can compare this to the previous UK GDP for the first quarter, reported flat at 0.0% quarterly, and which increased by 1.1% annualized. The final UK Total Business Investment for the first quarter decreased by 0.3% quarterly and increased by 0.8% annualized. Economists predicted a flat reading of 0.0...
Source: PaxForex Premium Analytics Portal, Fundamental Insight Pfizer (NYSE: PFE) has significantly underperformed the S&P 500 index, which in itself is not very good. It also lagged behind the S&P 500 in 2019. If you look at the last three years, five years or 10 years, Pfizer is not keeping up with the market as a whole. Pfizer has not been a winner for a long time. So, is it worth shorting the company's shares right now or should we wait? Investors were not happy after the last clinical failure of Pfizer. Earlier...
Source: PaxForex Premium Analytics Portal, Fundamental Insight Caterpillar's monthly retail sales figures (NYSE: CAT) are eagerly awaited by both shareholders and the market. They are a useful indicator of current trends, and the fact that they have recently shown some significant decline is not good news. There were some positive aspects to the report and the numbers were not as bad as they seem at first sight. The data shows that machine sales have been declining for six consecutive months. Obviously, this is worrying and...